Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes

Advances in Enzyme Regulation

Volumn 48, Issue 1, 2008, Pages 2-9

  Cocco, Lucio ^a   Faenza, Irene ^a   Follo, Matilde Y ^a   Ramazzotti, Giulia ^a   Gaboardi, Gian Carlo ^a   Billi, Anna Maria ^a   Martelli, Alberto M ^a,b   Manzoli, Lucia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C BETA; PROTEIN KINASE; PROTEIN KINASE B;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; AZACITIDINE; CELL DIFFERENTIATION; HUMANS; MYELODYSPLASTIC SYNDROMES; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C BETA; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 51349103842     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2007.11.013     Document Type: Article

References (28)

1. Cenciarelli C., De Santa F., Puri P.L., Mattei E., Ricci L., Bucci F., et al. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol 19 (1999) 5203-5217
2. Cheson B.D., Greenberg P.L., Bennett J.M., Lowenberg B., Wijermans P.W., Nimer S.D., et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 108 (2006) 419-425
3. Cocco L., Gilmour R.S., Ognibene A., Letcher A.J., Manzoli F.A., and Irvine R.F. Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation. Biochem J 248 (1987) 765-770
4. Cocco L., Martelli A.M., Fiume R., Faenza I., Billi A.M., and Manzoli F.A. Signal transduction within the nucleus: revisiting phosphoinositide inositide-specific phospholipase Cbeta1. Adv Enzyme Regul 46 (2006) 2-11
5. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100 (2002) 2957-2964
6. Faenza I., Matteucci A., Manzoli L., Billi A.M., Aluigi M., Peruzzi D., et al. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem 275 (2000) 30520-30524
7. Faenza I., Matteucci A., Bavelloni A., Marmiroli S., Martelli A.M., Gilmour R.S., et al. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. Biochim Biophys Acta 1589 (2002) 305-310
8. Faenza I., Bavelloni A., Fiume R., Lattanzi G., Maraldi N.M., Gilmour R.S., et al. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol 195 (2003) 446-452
9. Faenza I., Ramazzotti G., Bavelloni A., Fiume R., Gaboardi G.C., Follo M.Y., et al. Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin d3 promoter. Endocrinology 148 (2007) 1108-1117
10. Follo M.Y., Bosi C., Finelli C., Fiume R., Faenza I., Ramazzotti G., et al. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. Int J Mol Med 18 (2006) 267-271
11. Follo M.Y., Mongiorgi S., Bosi C., Cappellini A., Finelli C., Chiarini F., et al. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. Cancer Res 67 (2007) 4287-4294
12. Grandage V.L., Gale R.E., Linch D.C., and Khwaja A. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways. Leukemia 19 (2005) 586-594
13. Irvine R.F. Nuclear lipid signalling. Nat Rev Mol Cell Biol 4 (2003) 349-360
14. Kaminskas E., Farrell A., Abraham S., Baird A., Hsieh L.S., Lee S.L., et al. Approval summary: azacitidine for treatment of myelodysplastic syndrome subtypes. Clin Cancer Res 11 (2005) 3604-3608
15. Kowal-Vern A., Mazzella F.M., Cotelingam J.D., Shrit M.A., Rector J.T., and Schumacher H.R. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases. Am J Hematol 65 (2000) 5-13
16. Lo Vasco V.R., Calabrese G., Manzoli L., Palka G., Spadano A., Morizio E., et al. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia 18 (2004) 1122-1126
17. Manzoli F.A., Capitani S., Mazzotti G., Barnabei O., and Maraldi N.M. Role of chromatin phospholipids on template availability and ultrastructure of isolated nuclei. Adv Enzyme Regul 20 (1982) 247-262
18. Manzoli L., Martelli A.M., Billi A.M., Faenza I., Fiume R., and Cocco L. Nuclear phospholipase C: involvement in signal transduction. Prog Lipid Res 44 (2005) 185-206
19. Martelli A.M., Fala F., Faenza I., Billi A.M., Cappellini A., Manzoli L., et al. Metabolism and signaling activities of nuclear lipids. Cell Mol Life Sci 61 (2004) 1143-1156
20. Martelli A.M., Faenza I., Billi A.M., Manzoli L., Evangelisti C., Fala F., et al. Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis?. Cell Signal 18 (2006) 1101-1107
21. Martelli A.M., Nyakern M., Tabellini G., Bortul R., Tazzari P.L., Evangelisti C., et al. Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20 (2006) 911-928
22. Nyakern M., Tazzari P.L., Finelli C., Bosi C., Follo M.Y., Grafone T., et al. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients. Leukemia 20 (2006) 230-238
23. Samstag Y., and Nebl G. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB mediated signalling pathways in untransformed human peripheral blood T lymphocytes. Adv Enzyme Regul 45 (2005) 52-62
24. Schade A.E., Powers J.J., Wlodarski M.W., and Maciejewski J.P. Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 107 (2006) 4834-4840
25. Silverman L.R., Demakos E.P., Peterson B.L., Kornblith A.B., Holland J.C., Odchimar-Reissig R., et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20 (2002) 2429-2440
26. Wang Z., Sicinski P., Weinberg R.A., Zhang Y., and Ravid K. Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity. Genomics 35 (1996) 156-163
27. Yu H., Fukami K., Watanabe Y., Ozaki C., and Takenawa T. Phosphatidylinositol 4,5-bisphosphate reverses the inhibition of RNA transcription caused by histone H1. Eur J Biochem 251 (1998) 281-287
28. Zeng Z., Samudio I.J., Zhang W., Estrov Z., Pelicano H., Harris D., et al. Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia. Cancer Res 66 (2006) 3737-3746